hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

J&J Generics Deal May Speed AIDS Drug Access in Africa, India

Author: Alex Nussbaum, Bloomberg [USA], Published on: 28 January 2011

...Tibotec Pharmaceuticals [part of Johnson & Johnson]...has agreed to let three generic drugmakers provide copies of [its experimental AIDS drug] in sub-Saharan Africa, India and parts of Asia if it’s approved by regulators...[T]hat could make the pill available for a hundredth of the price that customers pay in the United States, said Mitchell Warren, executive director of the New York-based AIDS Vaccine Advocacy Coalition...The deal may have a downside if it means J&J is rejecting calls for drugmakers to license patents to The Medicines Patent Pool...[James] Love [director of Knowledge Ecology International] said...The agreements “are the first part of a comprehensive access strategy for TMC278,” Karen Manson, a Tibotec spokeswoman, said....

Read the full post here

Related companies: Johnson & Johnson Tibotec (part of Johnson & Johnson)